Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03918954
Other study ID # VGRVR
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2019
Est. completion date May 1, 2021

Study information

Verified date June 2020
Source Vastra Gotaland Region
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Sensory room is a new method in psychiatric inpatient care for management of anxiety. Since this method for anxiety management is being implemented more and more extensively within the psychiatric care system it is important to study its effect and whether there is any difference between physical and virtual sensory. In this study, the effect on mental well-being, pulse and blood pressure will be compared before and after each use of a virtual or physically sensory room. How the different methods affect the total care time, use of anxiety medication and results from self-assessment scales to measure depression and anxiety symptoms will also be looked at. The study will be conducted on two separate wards which primarily care for patients with the primary diagnosis of bipolar disorder.


Description:

This study will include about 100 research subjects admitted to an inpatient ward at the department of psychiatry for affective disorder. The study will be conducted in two inpatient wards. Patients who consent to participation will be offered to stay in a sensory room (a physical sensory room in one ward and a virtual sensory room via a pair of wireless VR glasses in another ward). In connection with the use of the virtual or physical sensory room, the patients will be given a visual analogue scale which asks the patient to rate their overall anxiety and mental health on a scale from 1 (feeling very bad) to 10 (feeling excellent). This will be the primary measure of the study. Before and after each visit the participant will have their pulse and blood pressure measured. Included patients will also be asked about participation in individual interviews. Semi-structured interviews will be carried out and collected data will be analyzed with a phenomenological approach. The purpose of this study is to shed light on experiences of staying in the digital and analogue sensory rooms. A number of self-rated questionnaires will be used in the project to establish the research subjects' level of depression and anxiety during their inpatient stay. - The Montgomery-Åsberg Depression Rating (MADRS-S) scale. MADRS-S is a self-assessment tool for assessing depression symptoms, it is used regularly in the clinic to evaluate depression symptoms. The inventory consists of a self-assessment form containing 9 statements intended to measure different depression symptoms. This scale is administered at the enrollment interview if patient consents to participation and once weekly until discharge. - Beck Anxiety Inventory (BAI) is a self-assessment instrument that measures the degree of anxiety. The inventory consists of a self-assessment form containing 21 statements intended to measure 21 different anxiety symptoms. This scale is administered at the enrollment interview if patient consents to participation and once weekly until discharge. - The Clinical Global Impressions (CGI) scale. CGI is a 7-scaled evaluation tool that requires the physician to determine the degree of the patient's disease at the time of assessment, in relation to the clinician's previous experience in patients with the same diagnosis. This scale is administered at the enrollment interview if patient consents to participation and once weekly until discharge.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 1, 2021
Est. primary completion date May 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Admitted to one of the two eligible inpatient units - Age over 18 years Exclusion Criteria: - Diagnosis of schizophrenia (ICD-10 F20) or schizoaffective disorder (ICD-10 F25) - Intellectual developmental disorder, organic brain injury or other condition that precludes informed consent - Active withdrawal symptoms from alcohol or other substances of abuse - Visual or balance disorder

Study Design


Intervention

Device:
Virtual sensory room
A pair of virtual reality glasses (Oculus Go) with installed the program Calm Place, a program designed for anxiety reduction.
Other:
Sensory room
A room with calming elements that patients can use to feel calm.

Locations

Country Name City State
Sweden Sahlgrenska University Hospital Gothenburg

Sponsors (2)

Lead Sponsor Collaborator
Vastra Gotaland Region Stockholm University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change on Visual Analogue Scale of anxiety A visual analogue scale from 0 (lowest) to 10 (highest) level of anxiety Immediately before and following the first administration of treatment
Secondary Beck´s Anxiety Scale Total score on 21 self-rated questions on anxiety (ranging from 0=no anxiety to 63=maximum level of anxiety) Once weekly from date of inclusion until the date of discharge up to 3 weeks
Secondary Montgomery-Åsberg Depression Rating Scale (MADRS-S) Depression grade on a self-rating scale ranging from 0=no depression to 54=most severe depression Once weekly from date of inclusion until the date of discharge up to 3 weeks
Secondary Use of anxiolytic medication Use in mg of anxiolytic medication Total use of medication from date of inclusion to date of discharge up to 3 weeks
Secondary Clinical Global Impression Clinician assessment of patient´s overall mental state ranging from 0 (no symptoms) to 7 (severe mental illness) Once weekly from date of inclusion until the date of discharge up to 3 weeks
Secondary Length of stay Number of days admitted to inpatient care Length of admission in days from date of inclusion to date of discharge up to a year
Secondary Blood pressure mmHg before and after intervention Immediately before and following first administration of treatment
Secondary Pulse Heartbeats per minute before and after intervention Immediately before and following first administration of treatment
Secondary Visual Analogue Scale of anxiety A visual analogue scale from 0 (lowest) to 10 (highest) level of anxiety An average of each immediate before and following measure of the administration of treatment
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A